Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

Abstract

A two-year-old FeLV infected cat was presented to the animal hospital due to reduced appetite and abdominal pain. Following diagnostic imaging and fine needle aspiration, intestinal lymphoblastic (high grade) lymphoma with additional alterations in the left kidney and spleen was diagnosed. Since...

Author(s)
Lahnstein, K.; Pippig, J.; Pack, A.; Rieger, M.
Publisher
Verlag M. & H, Schaper Gmbh, Hannover, Germany
Citation
Kleintierpraxis, 2018, 63, 11, pp 652...660
Abstract

Due to the aggressive biological behavior, a large number of studies attempt to identify the prognostic indicators for feline mammary carcinoma (FMC). In this study, we retrospectively identified the prognostic indicators and evaluated the effect of surgery with or without adjuvant chemotherapy on...

Author(s)
Lo TiYun; Feng YuChing; Yang YiPing; Liao JiunnWang; Chang ShihChieh
Publisher
Chinese Society of Veterinary Science, Taipei, Taiwan
Citation
Taiwan Veterinary Journal, 2019, 45, 3, pp 57-66
Abstract

Nineteen cats with relapsed high-grade/large-cell lymphoma were treated with dexamethasone, melphalan, actinomycin-D and cytarabine (DMAC). All cats had received Cyclophosphamide, Vincristine, Prednisolone (COP) as first-line chemotherapy and most cats had received at least 2 prior rescue agents...

Author(s)
Elliott, J.; Finotello, R.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2018, 16, 1, pp E144-E151
Abstract

Multi-drug chemotherapy protocols for feline lymphoma have demonstrated variable efficacy and tolerability. In phase I trials, lomustine has demonstrated efficacy for cats with lymphoma though its use for treatment naïve feline intermediate/large cell gastrointestinal (GI) lymphoma remains unknown. ...

Author(s)
Rau, S. E.; Burgess, K. E.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2017, 15, 3, pp 1019-1028
Abstract

Electrochemotherapy is characterized as a protocol which combines the use of antineoplastic agents and localized application of electric pulses (electroporation) to improve the intracellular concentration of these agents, increasing its cytotoxic action. Bleomycin, an antibiotic agent with ...

Author(s)
Silveira, L. M. G.; Cunha, F. M.; Brunner, C. H. M.; Xavier, J. G.
Publisher
Colégio Brasileiro de Patologia Animal, Rio de Janeiro, Brazil
Citation
Pesquisa Veterinária Brasileira, 2016, 36, 4, pp 297-302
Abstract

Suberoylanilide hydroxamic acid (SAHA), or vorinostat, is a histone deacetylase inhibitor approved for use as chemotherapy for lymphoma in humans. The goal of this study was to establish pharmacological parameters of SAHA in cats. Our interest in treating cats with SAHA is twofold: as an anticancer ...

Author(s)
McDonnel, S. J.; Tell, L. A.; Murphy, B. G.
Publisher
Wiley-Blackwell, Oxford, UK
Citation
Journal of Veterinary Pharmacology and Therapeutics, 2014, 37, 2, pp 196-200
Abstract

Cytotoxic drugs encapsulated into liposomes were originally designed to increase the anticancer response, while minimizing off-target adverse effects. The first liposomal chemotherapeutic drug was approved for use in humans more than 20 years ago, and the first publication regarding its use in a...

Author(s)
Børresen, B.; Hansen, A. E.; Kjær, A.; Andresen, T. L.; Kristensen, A. T.
Publisher
Wiley, Oxford, UK
Citation
Veterinary and Comparative Oncology, 2018, 16, 1, pp E1-E15
Abstract

This retrospective study evaluated the use of lomustine as a rescue agent for 39 cases of resistant feline lymphoma. Parameters assessed included lymphocyte cell size, number of previous chemotherapy drugs and number of previous chemotherapy protocols received, time from lymphoma diagnosis to...

Author(s)
Dutelle, A. L.; Bulman-Fleming, J. C.; Lewis, C. A.; Rosenberg, M. P.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Journal of Feline Medicine and Surgery, 2012, 14, 10, pp 694-700
Abstract

This study aimed to describe the signalment, clinical signs, magnetic resonance imaging (MRI) findings, cerebrospinal fluid (CSF) analysis, treatment, and outcome of feline meningoencephalomyelitis of unknown origin (FMUO). Medical records from 16 cats meeting the inclusion criteria of CSF...

Author(s)
Negrin, A.; Spencer, S.; Cherubini, G. B.
Publisher
Canadian Veterinary Medical Association, Ottawa, Canada
Citation
Canadian Veterinary Journal, 2017, 58, 10, pp 1073-1080
Abstract

Feline injection site sarcoma is a common tumor among cats, for which existing medical treatments do not prove to be entirely satisfactory. In this tumor, the platelet-derived growth factor receptor, a tyrosine kinase receptor, is frequently hyperactivated. In the past, clinical case reports with...

Author(s)
Ledoux, J. M.; Brun, P.; Chapuis, T.; Dumas, P.; Guillotin, J.
Publisher
Dove Medical Press Ltd, Macclesfield, UK
Citation
Veterinary Medicine: Research and Reports, 2014, 5, pp 109-112

Refine Results

Sort Order
Author
Geographical Location
Item Type
Language
Organisms
Subject Topics